Eli Lilly and Company
Utility Patents

Last updated:

List of all Eli Lilly and Company patents 128 in total

Status Patent
Grant
Utility: Accelerated testing method of silicone drainage in syringes External link
Filling date: 18 Sep 2025 Issue date: 21 Apr 2020
Grant
Utility: Anti-TrkA antibody External link
Filling date: 18 Sep 2025 Issue date: 14 Apr 2020
Grant
Utility: Dopamine D1 receptor positive allosteric modulators External link
Filling date: 18 Sep 2025 Issue date: 7 Apr 2020
Grant
Utility: BTLA agonist antibodies and uses thereof External link
Filling date: 18 Sep 2025 Issue date: 31 Mar 2020
Grant
Utility: Compounds useful for inhibiting ROR-gamma-t External link
Filling date: 18 Sep 2025 Issue date: 31 Mar 2020
Grant
Utility: Acylated insulin compound External link
Filling date: 18 Sep 2025 Issue date: 24 Mar 2020
Grant
Utility: Anti-Dkk-1-anti-RANKL bispecific antibody compounds External link
Filling date: 18 Sep 2025 Issue date: 10 Mar 2020
Grant
Utility: Anti-CGRP/anti-IL-23 bispecific antibodies and uses thereof External link
Filling date: 18 Sep 2025 Issue date: 3 Mar 2020
Grant
Utility: Methods for producing Fabs and bi-specific antibodies External link
Filling date: 18 Sep 2025 Issue date: 18 Feb 2020
Grant
Utility: Targeted treatment of leiomyosarcoma External link
Filling date: 18 Sep 2025 Issue date: 11 Feb 2020
Grant
Utility: Sensing system for medication delivery device External link
Filling date: 18 Sep 2025 Issue date: 21 Jan 2020
Grant
Utility: Inhibiting the transient receptor potential A1 ion channel External link
Filling date: 18 Sep 2025 Issue date: 31 Dec 2019
Grant
Utility: Anti-PACAP antibody External link
Filling date: 18 Sep 2025 Issue date: 31 Dec 2019
Grant
Utility: Anti-IL-33 antibodies and uses thereof for disease treatment External link
Filling date: 18 Sep 2025 Issue date: 10 Dec 2019
Grant
Utility: PD-1 agonist antibodies and uses thereof External link
Filling date: 18 Sep 2025 Issue date: 3 Dec 2019
Grant
Utility: Amino pyrimidine compounds useful as SSAO inhibitors External link
Filling date: 18 Sep 2025 Issue date: 12 Nov 2019
Grant
Utility: (E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-- carboxylate for inhibiting CDK7 External link
Filling date: 18 Sep 2025 Issue date: 12 Nov 2019
Grant
Utility: IL-17 antibody formulations and methods of treatment using same External link
Filling date: 18 Sep 2025 Issue date: 12 Nov 2019
Grant
Utility: Amino pyrimidine SSAO inhibitors External link
Filling date: 18 Sep 2025 Issue date: 5 Nov 2019
Grant
Utility: Notch pathway signaling inhibitor compounds External link
Filling date: 18 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Inhibiting the transient receptor potential A1 ion channel External link
Filling date: 18 Sep 2025 Issue date: 1 Oct 2019
Grant
Utility: Inactivation of viruses by delipidation External link
Filling date: 18 Sep 2025 Issue date: 24 Sep 2019
Grant
Utility: Acylated insulin compound External link
Filling date: 18 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: 1,4-Oxazines useful as selective BACE1 inhibitors External link
Filling date: 18 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: Sensing system for detecting a piston in a medical fluid container External link
Filling date: 18 Sep 2025 Issue date: 20 Aug 2019
Grant
Utility: 5-methyl-1,3,4-oxadiazol-2-yl compounds External link
Filling date: 18 Sep 2025 Issue date: 13 Aug 2019
Grant
Utility: Cyclobutyl-imidazolidinone compounds External link
Filling date: 18 Sep 2025 Issue date: 6 Aug 2019
Grant
Utility: Needle shield puller cap assembly External link
Filling date: 18 Sep 2025 Issue date: 30 Jul 2019

Showing 100 to 128 of 128 patents.